Blue Cross NC DRG Stimulation (Dorsal Root Ganglion) prior authorization requirements (2026)

Medical-necessity criteria Blue Cross NC generally applies

Dorsal Root Ganglion Stimulation - "Dorsal root ganglion (DRG) stimulation may be considered medically necessary as an alternative to dorsal column stimulation in patients with moderate-to-severe chronic intractable pain of the lower limbs from CRPS types I or II and who otherwise meet above criteria for spinal cord stimulator trial or implantation." Spinal Cord Stimulation (including burst, high frequency, and traditional stimulation methods) - Stimulator Trial: "may be considered medically necessary when ALL of the following criteria are met: The patient has chronic intractable neuropathic pain of the trunk and/or limbs associated with at least ONE of the following conditions: Lumbosacral arachnoiditis as documented by high levels of protein in the cerebrospinal fluid and/or imaging (MRI or myelography); Nerve root injuries that are post-surgical after a spine surgery (e.g., failed back surgery syndrome [FBSS]); Complex regional pain syndrome (CRPS), type I or type II ... which meets diagnostic criteria for CRPS (as per Budapest criteria); Painful diabetic neuropathy (PDN) when ALL of the following criteria are met: Evidence of painful PDN of at least 12 months; Lower limb pain intensity of >= 5 on the VAS scale; Objective evidence for presence of neuropathy and severity: moderate-severe neuropathy on EMG/NCS; Confirmation of PDN diagnosis by at least one other specialist (e.g., neurologist); BMI <= 35; HbA1c <= 10%; Daily morphine equivalents of 120 mg or less; Documented medical clearance as candidate for the procedure; Other causes of neuropathy have been ruled out; Optimization of medical management ...; Failed trial (or documented intolerance) to multiple pharmacologic agents in at least 2 categories ...; Absence of upper limb pain intensity of >= 3 on a VAS scale; Severe pain and disability with documented pathology or an objective basis for the pain; Dorsal column stimulation is being used as a late or last resort after documented failure of at least 6 consecutive months of physician-supervised multimodal conservative management; Failed trial of regional sympathetic blocks in the case of CRPS; There is no evidence of existing untreated drug addiction; The patient has been evaluated by a pain management specialist prior to implantation; ... At least one surgical opinion has been obtained to ensure that the patient does not have a surgically correctable lesion (excludes CRPS and PDN); Documentation of an evaluation by a licensed mental health provider within 6 months of a stimulator trial request ... that confirms no evidence of an inadequately controlled mental health problem (e.g., alcohol or drug dependence, depression, psychosis) that would negatively impact the success of a spinal cord stimulator or contraindicate its placement." "Spinal cord stimulator trial must be performed with percutaneously placed leads except under certain situations." Stimulator Implantation (Permanent): "The patient meets ALL of the criteria for a stimulator trial; A stimulator trial of at least 3 days duration has been performed; Documented pain reduction and functional improvement following the stimulator trial with at least a 50% reduction of target pain or analgesic medication use, and specific evidence of improved function." Replacement/revision/removal: hardware complication (lead migration, infection, painful generator site), end of life for battery change, patient intolerance, new neurologic deficits, or a planned MRI/AICD where the stimulator is contraindicated. [NEEDS CLINICAL SPOT-CHECK]

Commonly required documentation

• Budapest-criteria CRPS diagnosis of the lower limb plus Diagnosis meeting one of the listed conditions (CSF/MRI for arachnoiditis
• prior spine operative report for FBSS
• Budapest criteria for CRPS
• the full PDN checklist including EMG/NCS, second-specialist confirmation, BMI, HbA1c, MME)
• dated record of at least 6 consecutive months of physician-supervised multimodal conservative management
• sympathetic block results for CRPS
• pain-management specialist evaluation
• surgical opinion excluding a correctable lesion (not required for CRPS/PDN)
• licensed mental health evaluation within 6 months
• for permanent implant, trial log of >= 3 days with >= 50% pain reduction or analgesic reduction and specific functional gains.

Situations to verify before submitting

Blue Cross NC may not cover DRG Stimulation (Dorsal Root Ganglion) in these situations. Verify against the current policy rather than assuming a denial:

• {"text":"Exclusions: \"Use of spinal cord stimulation for the treatment of critical limb ischemia to forestall amputation, refractory angina pectoris, heart failure, and cancer-related pain; Repeat trial of spinal cord stimulation if the initial trial failed; Replacement of a conventional spinal cord stimulator with a burst, high frequency, or dorsal root ganglion stimulator in the absence of an indication for stimulator removal; Dorsal root ganglion neurostimulation for any non-CRPS lower extremity indication; Dorsal root ganglion neurostimulation in patients with CRPS lower extremity who currently have a functioning spinal cord stimulator or who have previously failed spinal cord stimulation therapy; Simultaneous placement of a dorsal column and dorsal root ganglion stimulator; Chronic, nonsurgical low back pain with or without a neuropathic component in patients with no history of prior lumbar spine surgery.\"","source":"https://guidelines.carelonmedicalbenefitsmanagement.com/interventional-pain-management-2026-06-14/"}

How to submit

• Method: Prior authorization is delegated to Carelon Medical Benefits Management for spine surgery, joint surgery, interventional pain management, and small joint surgery (Commercial Fully Insured since 2023-10-01; ASO groups only if the group elected the program, effective 2025-01-01 - verify by member ID on the Carelon portal or via the number on the member ID card). Submit through the Carelon Provider Portal via Blue e (24/7, real-time against Carelon clinical guidelines) or by phone at 866-455-8414, Monday-Friday 8 a.m.-6 p.m. ET. Applies in both outpatient and inpatient admission settings. Since 2025-07-01 (Fully Insured only; excludes Medicare Advantage, DSNP, EGWP, FEP and ASO), a request for a hospital-based OUTPATIENT setting for interventional pain or joint-arthroscopy/small-joint procedures gets an additional site-of-care review.
• Portal: Carelon Provider Portal (via Blue e)
• Typical turnaround: about 3 days

Sources & verification

• BindingSource - Carelon Clinical Appropriateness Guidelines: Interventional Pain Management (Interventional Pain Management 2026-06-14) · effective 2026-06-14.View
• BindingSource - Blue Cross NC Musculoskeletal Program and Interventional Pain Management effective October 1, 2023 (Carelon delegation) (Provider news 2023-10-01) · effective 2023-10-01.View

Binding = the payer's own policy. Proxy = a public, evidence-based clinical guideline the payer mirrors. Portal-only = the binding criteria are confirmed in the administrator's portal. Always confirm against the payer for the member's specific plan. Last verified 2026-09-20.

Frequently asked questions

Other Blue Cross NC prior authorization requirements

Related guides